483
Mohammed AnsariMohammed Ansari – FDA 483, Sep 16, 2021
Record Details
An FDA inspection of Texas Tech University Health Sciences Center in Lubbock, TX, identified a significant issue with the timely reporting of Serious Adverse Events (SAEs). The clinical investigator failed to adhere to the investigational plan and internal procedures, resulting in multiple instances of delayed SAE reporting to the Institutional Review Board (IRB). This indicates a lapse in human subject protection protocols.
View Company Profile
ID · 87083e1a-f786-42a6-9e15-b4126ade16ca
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.